Aspen Aerogels (NYSE:ASPN) Shares Cross Above 50-Day Moving Average - Should You Sell?

Key Points

• Aspen Aerogels shares recently crossed above their 50-day moving average of $7.13, trading as high as $7.30 with significant volume.
• Analysts have varied recommendations for Aspen Aerogels, with price targets ranging from $10.00 to $19.50, reflecting a consensus rating of "Moderate Buy."
• The company reported quarterly earnings that exceeded expectations, with a revenue of $78.02 million, despite a year-over-year decline of 33.8%.

Aspen Aerogels, Inc. (NYSE:ASPN - Get Free Report) crossed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of $7.13 and traded as high as $7.30. Aspen Aerogels shares last traded at $7.29, with a volume of 1,837,063 shares trading hands.

Analysts Set New Price Targets

ASPN has been the topic of a number of research analyst reports. Barclays downgraded shares of Aspen Aerogels from an "equal weight" rating to an "underweight" rating and increased their price objective for the company from $7.00 to $16.00 in a research note on Monday, August 11th. Canaccord Genuity Group reduced their price objective on shares of Aspen Aerogels from $11.00 to $10.00 and set a "buy" rating on the stock in a research note on Friday, August 8th. One equities research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $19.50.

Aspen Aerogels Stock Performance

The stock has a market cap of $599.99 million, a price-to-earnings ratio of -1.91 and a beta of 2.65. The company has a debt-to-equity ratio of 0.34, a quick ratio of 3.31 and a current ratio of 3.98. The company's 50 day simple moving average is $7.13 and its 200 day simple moving average is $6.44.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last released its earnings results on Thursday, August 7th. The construction company reported ($0.04) EPS for the quarter, beating the consensus estimate of ($0.12) by $0.08. The firm had revenue of $78.02 million for the quarter, compared to analysts' expectations of $72.53 million. Aspen Aerogels had a negative net margin of 78.53% and a positive return on equity of 2.92%. Aspen Aerogels's quarterly revenue was down 33.8% on a year-over-year basis. During the same quarter last year, the company earned $0.21 EPS. Aspen Aerogels has set its FY 2025 guidance at -3.860--3.730 EPS. On average, equities research analysts anticipate that Aspen Aerogels, Inc. will post 0.17 earnings per share for the current year.

Insider Buying and Selling at Aspen Aerogels

In other news, CAO Santhosh P. Daniel sold 4,410 shares of the firm's stock in a transaction dated Tuesday, August 12th. The shares were sold at an average price of $7.31, for a total transaction of $32,237.10. Following the completion of the transaction, the chief accounting officer owned 19,879 shares in the company, valued at approximately $145,315.49. This trade represents a 18.16% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Company insiders own 3.40% of the company's stock.

Hedge Funds Weigh In On Aspen Aerogels

Large investors have recently made changes to their positions in the business. Nisa Investment Advisors LLC boosted its position in shares of Aspen Aerogels by 1,094.8% during the 2nd quarter. Nisa Investment Advisors LLC now owns 4,791 shares of the construction company's stock valued at $28,000 after purchasing an additional 4,390 shares in the last quarter. SBI Securities Co. Ltd. boosted its position in shares of Aspen Aerogels by 67.3% during the 2nd quarter. SBI Securities Co. Ltd. now owns 6,343 shares of the construction company's stock valued at $38,000 after purchasing an additional 2,551 shares in the last quarter. Tower Research Capital LLC TRC boosted its position in shares of Aspen Aerogels by 184.6% during the 2nd quarter. Tower Research Capital LLC TRC now owns 7,235 shares of the construction company's stock valued at $43,000 after purchasing an additional 4,693 shares in the last quarter. Acadian Asset Management LLC bought a new position in shares of Aspen Aerogels during the 1st quarter valued at about $43,000. Finally, Banque Cantonale Vaudoise bought a new position in shares of Aspen Aerogels during the 1st quarter valued at about $45,000. Institutional investors own 97.64% of the company's stock.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.